Europese Unie - Nederlands - EMA (European Medicines Agency)

mylan ireland limited - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Europese Unie - Nederlands - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Europese Unie - Nederlands - EMA (European Medicines Agency)

teva gmbh - dimethylfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europese Unie - Nederlands - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethylfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europese Unie - Nederlands - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - dimethylfumaraat 120 mg - maagsapresistente capsule, hard - dimethyl fumarate

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - dimethylfumaraat 120 mg - maagsapresistente capsule, hard - dimethyl fumarate

Europese Unie - Nederlands - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - multiple sclerose, relapsing-remitting - immunosuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - dimethylfumaraat 240 mg - maagsapresistente capsule, hard - dimethyl fumarate

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - dimethylfumaraat 240 mg - maagsapresistente capsule, hard - dimethyl fumarate